These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6784923)

  • 21. [Combination therapy of continuous venous infusion (CVI) of 5-FU and low dose consecutive cisplatin (CDDP), and the new oral anti-cancer drug S-1 for advanced gastro-intestinal cancer].
    Shirasaka T; Aiba K; Araki H; Suzuki M; Terashima M; Mikami Y
    Gan To Kagaku Ryoho; 1999 Mar; 26(4):456-66. PubMed ID: 10097742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study on the concentration of FT-207 and 5-FU in serum, lymph nodes and tissues after administration of FT-207 suppositories].
    Kumazawa H; Imai N; Shioya M; Kato K; Fukaya Y; Noguchi A
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1655-62. PubMed ID: 6433799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conceptual changes in cancer chemotherapy--biochemical modulation of 5-FU from bench to clinic.
    Shirasaka T
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():193-205. PubMed ID: 10895155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of pre-operative chemotherapy using FT-207 suppositories combined with glutathione--with special reference to histopathological antitumor effect].
    Kaga F; Kitajima M; Ikeda Y; Seki M; Yagita A; Sohma S; Fukuzumi N
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):489-95. PubMed ID: 6820899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative pharmacokinetic analysis of 5-fluorouracil and its major metabolite 5-fluoro-5,6-dihydrouracil after conventional and reduced test dose in cancer patients.
    Bocci G; Danesi R; Di Paolo AD; Innocenti F; Allegrini G; Falcone A; Melosi A; Battistoni M; Barsanti G; Conte PF; Del Tacca M
    Clin Cancer Res; 2000 Aug; 6(8):3032-7. PubMed ID: 10955781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Concentrations of 5-fluorouracil (5-FU) in serum and tissues at venous injection of tegafur or 5-FU--clinical study on colorectal cancer].
    Kojima T; Suzumura K; Kanemitsu T; Miyashita A; Inamura Y; Owa Y; Naruse T
    Gan To Kagaku Ryoho; 1998 Mar; 25(4):547-51. PubMed ID: 9530361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Outpatient chemotherapy with continuous infusion of 5-fluorouracil (CI 5-FU) and intravenous bolus leucovorin (IVB LV) in advanced gastrointestinal cancer: the second report].
    Tsuji Y; Yoshihito H; Nakamura T; Watanabe Y; Nakayama N; Ohi M; Kawanishi J; Handa H; Honjo K; Uehara S
    Gan To Kagaku Ryoho; 1995 Dec; 22 Suppl 4():439-46. PubMed ID: 8849290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase I and pharmacokinetic study of oral UFT, a combination of the 5-fluorouracil prodrug tegafur and uracil.
    Muggia FM; Wu X; Spicer D; Groshen S; Jeffers S; Leichman CG; Leichman L; Chan KK
    Clin Cancer Res; 1996 Sep; 2(9):1461-7. PubMed ID: 9816321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
    Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
    Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical pharmacologic effects of thymidine plus 5-FU.
    Ohnuma T; Roboz J; Waxman S; Mandel E; Martin DS; Holland JF
    Cancer Treat Rep; 1980; 64(12):1169-77. PubMed ID: 7471111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase I trial of ftorafur combined with mitomycin C or methyl-CCNU in gastrointestinal cancers.
    Buroker T; Baker L; Correa J; Schwartz LA; Vailtkevicius VK
    Cancer Treat Rep; 1977; 61(3):463-7. PubMed ID: 326403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disposition and metabolism of 1-(tetrahydro-2-furanyl)-5-fluorouracil (ftorafur) in humans.
    Benvenuto JA; Lu K; Hall SW; Benjamin RS; Loo TL
    Cancer Res; 1978 Nov; 38(11 Pt 1):3867-70. PubMed ID: 359130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of chemotherapy of breast cancer (2). Clinical evaluation of the blood and tissue concentrations of FT-207 following intrarectal administration].
    Hiraide H; Mimura K; Kawano M; Hatsuse K; Kadota T; Kurokawa T; Tamaki K; Kanabe S; Mizoguchi O; Terashima H; Iwasa H
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 1):992-6. PubMed ID: 6408994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Invention of a tumor-selective 5-fluorouracil derivative named S-1 by biochemical modulation of 5-fluorouracil].
    Shirasaka T; Shimamoto Y; Kato T; Fukushima M
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):371-84. PubMed ID: 9492831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Study on the concentration of FT-207 and 5-FU in serum and tissues of bladder tumor and prostatic carcinoma].
    Kobayashi H; Sahashi M; Obata K
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2147-54. PubMed ID: 3087294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase I and pharmacokinetic study of tomudex combined with 5-fluorouracil plus levofolinic acid in advanced head and neck cancer and colorectal cancer.
    Caponigro F; Avallone A; McLeod H; Cartenì G; De Vita F; Casaretti R; Morsman J; Blackie R; Budillon A; De Lucia L; Gravina A; Catalano G; Comella P; Comella G
    Clin Cancer Res; 1999 Dec; 5(12):3948-55. PubMed ID: 10632324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Thermotherapy for cancer of the urinary bladder in combination with tegafur suppository and picibanil--concentrations of tegafur in the serum and tissues in bladder carcinoma].
    Murahashi I; Mukae K; Tabata Y; Sakuma H; Kanbe K; Arai T; Kaneko K; Honda M; Maeda S; Takasaki E
    Gan To Kagaku Ryoho; 1985 May; 12(5):1152-5. PubMed ID: 3922314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparison between FT-207 and 5-FU on intravesical absorption--experimental study on intravesical absorption in the dog].
    Nakagawa S; Kobayashi T; Nakao M; Toyoda K; Mishina T; Miyakoda K
    Hinyokika Kiyo; 1985 Jul; 31(7):1227-31. PubMed ID: 3933286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of thymidine on the toxicity and antitumor activity of ftorafur.
    Grossie VB; Loo TL
    Cancer Treat Rep; 1981; 65(11-12):1087-91. PubMed ID: 6794908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic study of S-1, a novel oral fluorouracil antitumor drug.
    Hirata K; Horikoshi N; Aiba K; Okazaki M; Denno R; Sasaki K; Nakano Y; Ishizuka H; Yamada Y; Uno S; Taguchi T; Shirasaka T
    Clin Cancer Res; 1999 Aug; 5(8):2000-5. PubMed ID: 10473078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.